Project Grant R21AA031567
Award Date
9/17/24
Completion Date
8/31/26
Dollars Obligated
$469K
Federal Agency
National Institute on Alcohol Abuse and Alcoholism
Federal Grant Program
93.273
Assistance Type
Project Grant
Place of Performance
Tallahassee, FL 32306, USA
Similar Awards
The University of Pittsburgh is the recipient of a $440,543 federal Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273). This award, titled "ROLE OF CELL TYPE-SPECIFIC MOLECULAR RHYTHM DISRUPTION IN ALCOHOL USE DISORDER," will be used to investigate how molecular circadian rhythms are altered in specific cell types within the nucleus accumbens of the human brain in individuals with alcohol use...
This federal Project Grant award of $517,248.00, provided by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273), aims to explore the mechanisms through which acute and chronic ethanol exposure regulate a signaling pathway involving norepinephrine, astrocytes, and dopamine neurons in the ventral periaqueductal gray (VPAG) region. The research is intended to understand how this pathway may contribute to acute and chronic...
This federal Project Grant award, provided by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), aims to investigate the role of the muscle circadian clock as a modifier of cancer cachexia. The $146,816 award, with a project period from July 1, 2025 to June 30, 2028, will fund research training to delineate the muscle clock profile and assess its impact on the development and...
This federal Project Grant award for $537,587, provided by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273), supports research to identify mechanisms responsible for the suppression of fibroblast growth factor 21 (FGF21) by interferon regulatory factor 3 (IRF3) in the context of alcohol use disorder (AUD) and alcohol-associated liver disease (ALD). The research aims to understand how the IRF3-PLAGL1 inhibitory axis regulates FGF21...
This $119,600 project grant, awarded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273), aims to investigate the cooperative mechanisms by which aging and alcohol consumption contribute to the development of alcohol-associated liver disease (ALD). The principal investigator at the University of Kansas Medical Center Research Institute, Inc. will focus on understanding how autophagy, endoplasmic reticulum stress, and lysosomal...
This Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273) federal grant program, provides $151,869 to support research investigating the relationship between alcohol consumption, metabolic function, and the progression of Alzheimer's disease (AD). The primary objectives of this 2-year project are to: 1) assess the impact of chronic ethanol exposure on metabolic function and tau pathology in an AD mouse model;...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) under CFDA 93.859 - Biomedical Research and Research Training Program provides $438,915 to Florida State University to conduct research on the genetic basis of circadian rhythms and sleep disorders. The key objectives of this 5-year award include: Identifying and characterizing pathogenic mutations in human clock genes that can cause alterations in chronotypes and sleep disorders through a novel...
This $482,000 federal Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (CFDA 93.273 - Alcohol Research Programs) to Texas Tech University System supports research to investigate how chronic excessive alcohol consumption impairs brown adipose tissue function and branched-chain amino acid (BCAA) utilization, leading to metabolic dysregulation. The key objectives are to: 1) characterize abnormal brown adipocyte phenotypes associated with BCAA utilization under chronic...
The federal Project Grant award of $591,502.96 from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) will support research by Washington State University (WSU) to evaluate the role of voluntary physical activity (PA) in reducing binge-like ethanol drinking in a genetic risk model for harmful drinking. The project aims to: 1) Determine the efficacy of voluntary PA to reduce binge-like ethanol drinking in a mouse model, 2) Identify...
This Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273) federal grant program, will fund the development and testing of a novel in vivo model called CHIMERA-BONCAT to comprehensively characterize the human microglial response to alcohol exposure. The $214,385 award will support two key objectives: 1) Characterizing the reactivity of human microglia derived from induced pluripotent stem cells (iPSCs) to...